• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket

    8/10/22 6:08:46 AM ET
    $ABCL
    $AEMD
    $AGLE
    $ALC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ABCL alert in real time by email

    Gainers

    • ObsEva SA (NASDAQ:OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) shares rose 30.8% to $0.54 in pre-market trading. Aeglea BioTherapeutics, last week, reported a Q2 loss of $0.27 per share.
    • CarLotz, Inc. (NASDAQ:LOTZ) shares rose 30.6% to $0.7403 in pre-market trading after the company reported financial results and announced a merger agreement with Shift Technologies Inc.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) rose 25.6% to $0.1520 in pre-market trading after declining around 7% on Tuesday.
    • BARK, Inc. (NYSE:BARK) rose 20.3% to $2.13 in pre-market trading following better-than-expected Q1 results.
    • SilverSun Technologies, Inc. (NASDAQ:SSNT) shares rose 17.4% to $4.32 in pre-market trading after jumping over 19% on Tuesday.
    • The Trade Desk, Inc. (NASDAQ:TTD) rose 17.3% to $63.90 in pre-market trading after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates.
    • Synalloy Corporation (NASDAQ:SYNL) rose 15.2% to $15.30 in pre-market trading after reporting a sharp rise in quarterly earnings.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) rose 14.5% to $1.50 in pre-market trading following strong Q1 earnings.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares rose 13.5% to $0.3580 in pre-market trading.
    • Ra Medical Systems, Inc. (NASDAQ:RMED) rose 11.2% to $0.1870 in pre-market trading after declining 11% on Tuesday. Ra Medical recently announced it entered into agreements to raise $$6.2 million through previously issued warrants.
    • NewAge, Inc. (NASDAQ:NBEV) rose 10.3% to $0.29 in pre-market trading.
    • Array Technologies, Inc. (NASDAQ:ARRY) rose 9.6% to $20.04 in pre-market trading after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Athersys, Inc. (NASDAQ:ATHX) rose 6.4% to $0.2949 in pre-market trading after dropping around 8% on Tuesday.
    • AMTD IDEA Group (NYSE:AMTD) rose 5.1% to $2.48 in pre-market trading after dipping more than 20% on Tuesday.
    • Twitter, Inc. (NYSE:TWTR) rose 4.3% to $44.65 in pre-market trading after Elon Musk sold Tesla shares and tweets about importance of avoiding emergency stock sale in "unlikely" event of forced deal.
    • Tesla, Inc. (NASDAQ:TSLA) rose 2.5% to $871.21 in pre-market trading. Tesla CEO Elon Musk sold $6.85 billion worth of the electric-vehicle maker's shares, according to filings made with the U.S. Securities and Exchange Commission on Tuesday.


    Don’t forget to check out our premarket coverage here .

    Losers

    • OptimizeRx Corporation (NASDAQ:OPRX) shares fell 21.8% to $17.40 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares fell 20.4% to $2.18 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
    • PLBY Group, Inc. (NASDAQ:PLBY) shares fell 16.5% to $5.82 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results.
    • Roblox Corporation (NASDAQ:RBLX) fell 14.4% to $40.52 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and announced bookings were 4% down year over year.
    • Evotec SE (NASDAQ:EVO) fell 12.4% to $12.35 in pre-market trading. Evotec Biologics and Alpine Immune Sciences expanded partnership for commercial process development of ALPN-303.
    • Nextdoor Holdings, Inc. (NASDAQ:KIND) fell 12.2% to $3.16 in pre-market trading after the company reported downbeat Q2 results and issued weak Q3 forecast.
    • Immatics N.V. (NASDAQ:IMTX) fell 11% to $11.06 in pre-market trading. Immatics, on Tuesday, reported Q2 sales of $17.9 million.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 7.8% to $80.87 in pre-market trading after the company reported a wider-than-expected loss for its second quarter and also shared an updated full year guidance.
    • Vertex Energy, Inc. (NASDAQ:VTNR) fell 7.6% to $7.21 in pre-market trading. HC Wainwright & Co. maintained Vertex Energy with a Buy and lowered the price target from $25 to $15. Vertex Energy shares dipped 44% on Tuesday after the company reported worse-than-expected Q2 EPS.
    • AbCellera Biologics Inc. (NASDAQ:ABCL) fell 7.3% to $10.29 in pre-market trading following downbeat Q2 sales.
    • Alcon Inc. (NYSE:ALC) shares fell 5.6% to $71.21 in pre-market trading after the company reported Q2 results.
    Get the next $ABCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCL
    $AEMD
    $AGLE
    $ALC

    CompanyDatePrice TargetRatingAnalyst
    The Trade Desk Inc.
    $TTD
    2/26/2026$17.00Neutral → Sell
    New Street
    The Trade Desk Inc.
    $TTD
    2/26/2026$25.00Buy → Hold
    Loop Capital
    Array Technologies Inc.
    $ARRY
    2/26/2026$9.00Buy → Hold
    Deutsche Bank
    Alcon Inc.
    $ALC
    2/26/2026$97.00Equal Weight → Overweight
    Wells Fargo
    Array Technologies Inc.
    $ARRY
    2/25/2026$19.00Neutral → Outperform
    BNP Paribas Exane
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Roblox Corporation
    $RBLX
    2/9/2026$84.00Neutral → Buy
    Roth Capital
    More analyst ratings

    $ABCL
    $AEMD
    $AGLE
    $ALC
    SEC Filings

    View All

    SEC Form 10-K filed by BigBear.ai Inc.

    10-K - BigBear.ai Holdings, Inc. (0001836981) (Filer)

    3/2/26 4:33:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    BigBear.ai Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - BigBear.ai Holdings, Inc. (0001836981) (Filer)

    3/2/26 4:18:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Roblox Corporation filed SEC Form 8-K: Leadership Update

    8-K - Roblox Corp (0001315098) (Filer)

    3/2/26 7:52:00 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BigBear.ai Announces Fourth Quarter 2025 Results; Releases 2026 Financial Outlook

    Closed 2025 with strongest financial position in Company history Total cash and investments of $462 million as of December 31, 2025 Settled the remaining $125 million of 2029 Convertible notes, primarily through the Company's exercise of debt-to-equity conversion features in January 2026. Closed acquisitions of Ask Sage (December 2025), and CargoSeer (January 2026), and expanded into the Middle East, which positions the Company for solid growth in 2026 The Company projects full-year 2026 revenue between $135 million and $165 million, representing approximately 17% growth at the midpoint compared to full-year 2025 revenue of $128 million BigBear.ai Holdings, Inc. (NYSE:BBAI)

    3/2/26 4:15:00 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.474 Million Tokens, and Total Crypto and Total Cash Holdings of $9.9 Billion

    Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,976 per ETH; MAVAN staking solution on track to launch Q1 2026Bitmine now owns 3.71% of the ETH token supply, over 74% of the way to the 'Alchemy of 5%' in just 8 monthsBitmine recently closed on initial $200 million investment into Beast IndustriesBitmine Crypto + Total Cash Holdings + "Moonshots" total $9.9 billion, including 4.474 million ETH tokens, total cash of $868 million, and other crypto holdingsBitmine leads crypto treasury peers by both the velocity of raising crypto NAV per share and by the high trading liquidity of BMNR stockBitmine is the 145th most traded stock in the US, trading $0.8 billion per day (5-day avg

    3/2/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Alcon Surpasses 175 Million IOLs Implanted Globally

    Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom from glasses; Vivity has a proven exceptionally low rate of visual disturbances2-8,**,Δ,§,^,‡ Alcon is committed to furthering innovation in the IOL space and plans to launch new technologies in key markets this year Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been implanted worldwide.9,+ Alcon has more than 30 years of IOL experience with its robust portfolio

    3/2/26 8:03:00 AM ET
    $ALC
    Ophthalmic Goods
    Health Care

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Thermopylae Holdings Ltd. bought $130,720 worth of shares (38,000 units at $3.44), increasing direct ownership by 0.07% to 56,134,097 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    3/2/26 2:16:40 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Wilson-Thompson Kathleen exercised 40,000 shares at a strike of $14.99 and sold $10,692,814 worth of shares (25,731 units at $415.56), increasing direct ownership by 264% to 19,669 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    2/27/26 7:00:21 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Large owner Thermopylae Holdings Ltd. bought $580,284 worth of shares (177,457 units at $3.27), increasing direct ownership by 0.32% to 56,096,097 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    2/27/26 4:20:01 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Thermopylae Holdings Ltd. bought $130,720 worth of shares (38,000 units at $3.44), increasing direct ownership by 0.07% to 56,134,097 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    3/2/26 2:16:40 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Thermopylae Holdings Ltd. bought $580,284 worth of shares (177,457 units at $3.27), increasing direct ownership by 0.32% to 56,096,097 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    2/27/26 4:20:01 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Booth Andrew bought $145,692 worth of shares (42,600 units at $3.42), increasing direct ownership by 28% to 195,600 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    2/27/26 2:48:34 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Trade Desk downgraded by New Street with a new price target

    New Street downgraded The Trade Desk from Neutral to Sell and set a new price target of $17.00

    2/26/26 7:12:57 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk downgraded by Loop Capital with a new price target

    Loop Capital downgraded The Trade Desk from Buy to Hold and set a new price target of $25.00

    2/26/26 7:11:50 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Array Tech downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Array Tech from Buy to Hold and set a new price target of $9.00

    2/26/26 7:10:22 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Leadership Updates

    Live Leadership Updates

    View All

    Playboy Appoints David Miller as President, Media & Brand

    Media Veteran Miller to Oversee Global Licensing, Digital and Platform Growth Senior Appointment Reflects Playboy's Accelerating Growth Strategy and Expanding Media and Licensing Operations LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Playboy, Inc. (NASDAQ:PLBY) ("Playboy" or the "Company"), a global pleasure and leisure company, has announced that David Miller has been appointed President, Media & Brand, to drive the next phase of the Company's growth. Miller joins Playboy from The Walt Disney Company, where he served as Executive Vice President and General Manager of National Geographic Media, with full P&L responsibility across global editorial, digital, print, and social operation

    2/26/26 8:31:00 AM ET
    $PLBY
    Other Specialty Stores
    Consumer Discretionary

    The Trade Desk Introduces the Ventura Ecosystem to Advance the Future of CTV Advertising; V and Nexxen Join as the First Collaborators

    The Ventura Ecosystem aims to unite global TV operating systems and industry partners to create a more transparent, collaborative, and revenue-optimized marketplace for CTV advertising Today, The Trade Desk's Ventura, the platform built for a fairer and more transparent streaming ecosystem, takes the next step in its vision to optimize programmatic advertising in connected TV (CTV) with the launch of the Ventura Ecosystem. The Ventura Ecosystem is an industry collaboration that brings global TV operating systems and streaming platforms together to create a more transparent and revenue‑optimized marketplace, so the industry can continue to grow and thrive. Through the Ventura Ecosystem, pa

    2/24/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Financials

    Live finance-specific insights

    View All

    ARRAY Technologies Reports Financial Results for the Fourth Quarter and Full Year 2025

    Achieves 40% Full-Year Revenue Growth, Record Orderbook of $2.2 Billion, Further Expands DuraTrack® Technology to Global Markets and Guides 2026 Revenue to $1.4 Billion to $1.5 Billion 2025 Fourth Quarter Business Highlights Total executed contracts and awarded orders at December 31, 2025 were $2.2 billion(1)Achieved 2x book-to-bill for both total ARRAY and APADuraTrack introduced to global markets to align with customer demand for patented, superior energy performance of wind-stow technology 2025 Fourth Quarter and Full-Year Financial Highlights (in millions, except per share)4Q 2025 FY 2025Revenue$226.0  $1,284.1 Gross margin(2) 8.6%  23.2%Adjusted gross margin(3) 24.5%  27.0%Net loss t

    2/25/26 4:05:00 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    The Trade Desk Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    The Trade Desk also announced an additional share repurchase authorization, bringing the total amount of authorized future repurchases to $500 million of its Class A common stock. The Trade Desk, Inc. ("The Trade Desk," the "Company" or "we") (NASDAQ:TTD), a provider of a global technology platform for buyers of advertising, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "The Trade Desk delivered $2.9 billion in revenue in 2025 while continuing to generate significant profitability and cash flow," said Jeff Green, Co-Founder and CEO of The Trade Desk. "We executed against a backdrop of macro uncertainty while making some of the most mea

    2/25/26 4:01:00 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

    Fourth-quarter 2025 sales of $2.7 billion, up 9% on a reported basis, or up 7% constant currency1 (cc), versus fourth-quarter 2024 Fourth-quarter 2025 diluted EPS of $0.44; core diluted EPS2 of $0.78 Generated $2.3 billion of cash from operations and $1.7 billion of free cash flow3 in full-year 2025 Returned $848 million to shareholders through share repurchases and dividends Ad Hoc Announcement Pursuant to Art. 53 LR Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve month periods ending December 31, 2025. For the fourth quarter of 2025, sales were $2.7 billion, up 9% on a reported basis and up 7% on a constant curren

    2/24/26 4:30:00 PM ET
    $ALC
    Ophthalmic Goods
    Health Care

    $ABCL
    $AEMD
    $AGLE
    $ALC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology